The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,804.00
Bid: 1,813.00
Ask: 1,816.00
Change: 14.00 (0.78%)
Spread: 3.00 (0.165%)
Open: 1,788.00
High: 1,827.00
Low: 1,770.00
Prev. Close: 1,790.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Johnson Matthey business update

7 Feb 2018 07:00

RNS Number : 0785E
Johnson Matthey PLC
07 February 2018
 

Johnson Matthey business update

 

Johnson Matthey today provides an update on two business matters: the settlement of the contract dispute lawsuit reported as a contingent liability in November 2017; and the positive impact of US tax legislation on the group.

Settlement of after treatment contract lawsuit

As announced on 21st November 2017, a group company, Johnson Matthey Inc. (JMI), had been made a defendant to a contract dispute lawsuit alongside a supplier to an automotive OEM in the United States. The dispute related to a component supplied by the group. We reported a contingent liability in relation to the lawsuit in the announcement of our half year results for the six months ended 30th September 2017.

 

Today we announce that the lawsuit against JMI has been settled on mutually acceptable terms with no admission of fault. Under this settlement agreement, Johnson Matthey will recognise a charge of £50 million in connection with resolution of the lawsuit. This charge will be excluded from underlying operating profit for the year ending 31st March 2018.

 

Positive impact of US tax legislation on Johnson Matthey

We note the approval of the US Tax Cuts and Jobs Act, which became generally effective 1st January 2018, and expect to be positively impacted by these changes.

 

The lowering of the US corporate tax rate leads to a revaluation of our US deferred tax liabilities, which we estimate will result in a £30 million one-off non-cash benefit in the income tax expense line in the income statement for the year ending 31st March 2018. This will be excluded from the tax on underlying profit.

 

For the current financial year to 31st March 2018, we anticipate no change to the effective tax rate on underlying profit. We continue to expect this to be around 18%. Looking forward to the financial year ending 31st March 2019 and beyond we expect these changes will reduce the effective tax rate on underlying profit by around two percentage points. We continue to work through the full impact and will give more detail in our preliminary announcement for the year ending 31st March 2018.

 

Outlook

Our outlook for the year ending 31st March 2018 remains unchanged.

 

Enquiries:

Analysts and investors:

Martin Dunwoodie +44 (0)20 7269 8241

Simon McGough +44 (0)20 7269 8235

Katharine Burrow +44 (0)20 7269 8444

Media:

Sally Jones +44 (0)20 7269 8407

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDTFMJTMBAMBIP
Date   Source Headline
14th Jul 202210:01 amRNSHolding(s) in Company
12th Jul 20224:11 pmRNSHolding(s) in Company
8th Jul 20224:25 pmRNSHolding(s) in Company
8th Jul 202211:00 amRNSHolding(s) in Company
6th Jul 202211:32 amRNSHolding(s) in Company
17th Jun 202211:38 amRNSDirector/PDMR Shareholding
17th Jun 20229:30 amRNSHolding(s) in Company
15th Jun 202210:33 amRNSAnnual Financial Report
14th Jun 202212:45 pmRNSDirector/PDMR Shareholding
10th Jun 20225:21 pmRNSHolding(s) in Company
6th Jun 202211:20 amRNSHolding(s) in Company
1st Jun 20229:00 amRNSTotal Voting Rights
1st Jun 20227:00 amRNSJohnson Matthey completion of Health sale
30th May 202211:20 amRNSDirector/PDMR Shareholding
27th May 20224:50 pmRNSHolding(s) in Company
27th May 20224:48 pmRNSHolding(s) in Company
27th May 20224:45 pmRNSHolding(s) in Company
26th May 20227:00 amRNSJohnson Matthey FY results and strategy update
26th May 20227:00 amRNSJohnson Matthey sale of Battery Materials
25th May 20224:04 pmRNSHolding(s) in Company
25th May 20221:24 pmRNSJohnson Matthey expands presence in green hydrogen
19th May 202210:30 amRNSDirector/PDMR Shareholding
17th May 20224:01 pmRNSHolding(s) in Company
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares
12th May 20227:00 amRNSTransaction in Own Shares
11th May 20227:00 amRNSTransaction in Own Shares
10th May 20227:00 amRNSTransaction in Own Shares
9th May 202211:45 amRNSHolding(s) in Company
9th May 20227:00 amRNSTransaction in Own Shares
4th May 20224:26 pmRNSHolding(s) in Company
3rd May 20225:55 pmRNSHolding(s) in Company
3rd May 20224:04 pmRNSTotal Voting Rights
3rd May 20227:00 amRNSTransaction in Own Shares
29th Apr 20227:00 amRNSHolding(s) in Company
29th Apr 20227:00 amRNSTransaction in Own Shares
28th Apr 202212:06 pmRNSHolding(s) in Company
28th Apr 20227:00 amRNSTransaction in Own Shares
27th Apr 20227:00 amRNSTransaction in Own Shares
26th Apr 20229:00 amRNSHolding(s) in Company
26th Apr 20227:00 amRNSTransaction in Own Shares
25th Apr 20227:00 amRNSTransaction in Own Shares
22nd Apr 20227:00 amRNSTransaction in Own Shares
21st Apr 20224:49 pmRNSHolding(s) in Company
21st Apr 202212:15 pmRNSDirector/PDMR Shareholding
21st Apr 20227:00 amRNSTransaction in Own Shares
20th Apr 20227:00 amRNSTransaction in Own Shares
19th Apr 20227:00 amRNSTransaction in Own Shares
14th Apr 20227:00 amRNSTransaction in Own Shares
13th Apr 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.